Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05051098 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Non-interventional Registry for Patients With Hepatitis B Virus Infection

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 years later Dec 2025 → Dec 31, 2031
See other at-risk trials from Hannover Medical School

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2025 to Dec 31, 2031
    • Eligibility criteria expanded, about 10 words
  2. Primary completion date: Dec 2024 to Dec 2025v3
  3. Primary completion date: May 2022 to Dec 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).
Trial Details
NCT Number NCT05051098
Lead Sponsor Hannover Medical School
Collaborators: European Union, German Center for Infection Research, German Liver Foundation (DLS)
Conditions
(from sponsor)		 Hepatitis B Virus Infection
Related terms Hepatitis B
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov